Skip to main content

Venous Thrombosis - 1 CME Credit

Diagnosing and managing adult patients with DVT and inherited thrombophilia

Start Date: July 17, 2018
Duration: ~ 1 hour
Price: $49

Course Description

The most common presentations of venous thromboembolism (VTE) are deep vein thrombosis (DVT) of the lower extremity and pulmonary embolism. A risk factor for VTE, either hereditary or acquired, can now be identified in approximately 80 percent of patients. Furthermore, there is often more than one factor at play in a given patient. As an example, 50 percent of thrombotic events in patients with inherited thrombophilia are associated with an acquired risk factor (eg., surgery, pregnancy, oral contraceptives). In addition, some patients have more than one form of inherited thrombophilia and appear to be at greater risk for thrombosis.

The approach to the adult patient with deep venous thrombosis will be discussed here with an emphasis upon the use of diagnostic tests to establish an accurate diagnosis and the initiation of anticoagulant therapy. Indications for testing for an inherited cause of thrombophilia are addressed along with the potential implications of the discovery of an underlying thrombophilic defect for the patient and affected relatives.

This course is intended for primary care and specialty physicians, physician assistants, and nurse practitioners who may encounter patients with venous thrombosis in their practices.

What You'll Learn

  • Identify appropriate steps in diagnosing deep venous thrombosis
  • Describe the benefits of parenteral and oral anticoagulant therapy
  • Discuss new information related to genetic prothrombotic risk factors

Want to purchase this course for a group?

You can purchase enrollment codes for this course to distribute to your team

Purchase for a Group

Instructors

Kenneth Bauer, MD

Kenneth Bauer, MD Professor of Medicine, Harvard Medical School; Chief, Hematology Division, New England Baptist Hospital

David Feinbloom, MD

David Feinbloom, MD Assistant Professor of Medicine, Harvard Medical School; Medical Director, Medication Safety and Information Management, Silverman Institute for Healthcare Quality, Beth Israel Deaconess Medical Center

COURSE OUTLINE

Venous Thrombosis is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Grading and Certificates

Welcome to Venous Thrombosis
Case Presentation
Diagnosis
Treatment
Case Summary
Additional Information
References

CME Certificate
CME Posttest
Course Evaluation

ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

ACCREDITATION STATEMENT

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

The Harvard Medical School designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT

Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: Kenneth A. Bauer, MD
Relationship: Consultant
Company: Janssen Pharmaceuticals

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

COURSE DIRECTORS

Dr. Kenneth Bauer is a professor of medicine at Harvard Medical School. His hospital positions include chief of the Hematology Section, VA Boston Healthcare System and director of Thrombosis Clinical Research at Beth Israel Deaconess Medical Center in Boston. Dr. Bauer received his medical degree from Stanford University School of Medicine in Stanford, California. He completed his residency in medicine at the University of Chicago hospitals and clinics in Illinois. He was a fellow in Medical Oncology and a clinical/research fellow in the Division of Thrombosis and Hemostasis at Dana Farber Cancer Institute and was also a clinical/research fellow in the Hematology-Oncology Division at Beth Israel Deaconess Medical Center. Dr Bauer’s research interests include elucidation of the mechanisms leading to the development of a prethrombotic state and clinical evaluation of new antithrombotic drugs. Dr. Bauer previously served as chairman of council of the International Society on Thrombosis and Haemostasis (ISTH) and is vice-president and was scientific program chair (clinical) for the XXIInd ISTH Congress held in Boston in 2009. Dr Bauer has published over 200 original reports, reviews, and book chapters.

Dr. David Feinbloom is an assistant professor of medicine at Harvard Medical School and an academic hospitalist at Beth Israel Deaconess Medical Center. Dr. Feinbloom received his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed his residency in medicine at the Beth Israel Deaconess Medical Center in Boston. Dr. Feinbloom’s research interests include the development of clinical pathways for the diagnosis, prevention, and treatment of VTE, and the use of new antithrombotic drugs.

COURSE RELEASE DATES

Venous Thrombosis:
Original Release: 8/8/2007
Most Recent Update: 7/17/2018

FREQUENTLY ASKED QUESTIONS

How long will this course take?

This course should take approximately 1 hour to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.

Enroll